NCT01789775View on ClinicalTrials.gov

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea

PHASE3CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Rosacea
Interventions
DRUG

Drug: CD07805/47 gel

DRUG

CD07805/47 gel Placebo

Trial Locations (7)

34

Galderma Investigational Site, Montpellier

06

Galderma Investigational Site, Nice

Unknown

Galderma Investigational Site, Chelyabinsk

Galderma Investigational Site, Moscow

Galderma Investigational Site, Saint Petersburg

Galderma Investigational Site, Yekaterinburg

Galderma Investigational Site, Eskilstuna

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY